LON:MCGN - Microgen Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
GBX 460 -2.00 (-0.43 %)
(As of 06/22/2018 04:00 PM ET)
Previous CloseGBX 460
Today's RangeGBX 460 - GBX 472
52-Week RangeGBX 260 - GBX 512
Volume138,268 shs
Average Volume122,482 shs
Market Capitalization£300.09 million
P/E RatioN/A
Dividend YieldN/A
Microgen logoMicrogen plc, together with its subsidiaries, develops, implements, and supports business critical software and related services in the United Kingdom and internationally. It operates through two segments, Aptitude Software and Microgen Financial Systems. The Aptitude Software segment provides a suite of specialized finance management software applications for banking, healthcare, insurance, and telecommunications customers. Its applications include Aptitude Insurance Calculation Engine that focuses on insurance contracts; Aptitude Lease Accounting Engine, which addresses leasing standards; Aptitude Revenue Recognition Engine for revenue recognition requirements; Aptitude RevStream, a cloud-enabled revenue management software; Aptitude Accounting Hub that transforms financial, management, and statutory accounting; and Aptitude Allocation Engine that offers interfaces to set-up and apply rules to allocate cost and revenue. This segment licenses its software; and provides software maintenance/support, software subscriptions for its cloud-based offerings; and implementation services. The Microgen Financial Systems segment offers Microgen 5Series, a wealth management software for both on-shore and off-shore markets; and Microgen Bacway, a suite of payments software products. It also provides maintenance, support, and development services on a range of software products and applications developed by third parties. Microgen plc was founded in 1974 and is headquartered in London, the United Kingdom.

Receive MCGN News and Ratings via Email

Sign-up to receive the latest news and ratings for MCGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Technical & System Software
SectorComputer and Technology


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins14.56%
Return on Equity18.41%
Return on Assets9.99%


Outstanding Shares60,860,000

The Truth About Cryptocurrencies

Microgen (LON:MCGN) Frequently Asked Questions

What is Microgen's stock symbol?

Microgen trades on the London Stock Exchange (LON) under the ticker symbol "MCGN."

How often does Microgen pay dividends? What is the dividend yield for Microgen?

Microgen declared a dividend on Wednesday, March 7th. Investors of record on Thursday, May 3rd will be paid a dividend of GBX 4.25 per share on Friday, May 25th. This represents a dividend yield of 0.87%. The ex-dividend date is Thursday, May 3rd. This is a positive change from Microgen's previous dividend of $2.00. The official announcement can be seen at this link. View Microgen's Dividend History.

What price target have analysts set for MCGN?

1 Wall Street analysts have issued 12 month price objectives for Microgen's stock. Their forecasts range from GBX 400 to GBX 400. On average, they expect Microgen's stock price to reach GBX 400 in the next twelve months. View Analyst Ratings for Microgen.

Who are some of Microgen's key competitors?

Who are Microgen's key executives?

Microgen's management team includes the folowing people:
  • Mr. Philip B. Wood ACA, CFO, Group Fin. Director, Exec. Director and Member of the Operating Board (Age 45)
  • Mr. Tom Crawford, Chief Exec. Officer of Aptitude Software and Exec. Director (Age 50)
  • Mr. Simon Baines, Chief Exec. Officer of Microgen Financial Systems and Exec. Director (Age 47)
  • Mark Heather, Company Sec.
  • Martin Redington, Chief Technology Officer of Aptitude Software

Has Microgen been receiving favorable news coverage?

News headlines about MCGN stock have trended somewhat positive on Saturday, Accern reports. The research firm scores the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Microgen earned a news impact score of 0.01 on Accern's scale. They also gave media headlines about the company an impact score of 46.76 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Microgen?

Shares of MCGN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Microgen's stock price today?

One share of MCGN stock can currently be purchased for approximately GBX 460.

How big of a company is Microgen?

Microgen has a market capitalization of £300.09 million.

How can I contact Microgen?

Microgen's mailing address is Old Change House 128 Queen Victoria Street, LONDON, EC4V 4BJ, United Kingdom. The company can be reached via phone at +44-20-74968100.

MarketBeat Community Rating for Microgen (MCGN)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  136 (Vote Underperform)
Total Votes:  230
MarketBeat's community ratings are surveys of what our community members think about Microgen and other stocks. Vote "Outperform" if you believe MCGN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MCGN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.